How do you embrace disruption while providing stability? Three business luminaries share insights about the delicate balance required for effective transformation.

Vertex Pharmaceuticals Incorporated today announced several updates on the Company's type 1 diabetes (T1D) portfolio. VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of the ...

Artificial Intelligence (AI) is set to revolutionise industries in 2025, with emerging technologies such as Agentic AI, MLOps platforms, and foundational models driving unprecedented advancements in ...

How can we preserve the power of code-based approaches while making them accessible to creators across all skill levels?

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp. (MSFT), NVIDIA Corp.

Learn more about whether Elastic N.V. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

Endiya actively assists portfolio companies with product rollouts, customer acquisition hiring, and preparing for future ...

Deimos and Salus Cloud partner to integrate AI-powered security automation on Google Cloud, enhancing DevSecOps efficiency, reducing risks, and accelerating deployments.

By integrating GenAI and Google Cloud’s Vertex AI platform, Deimos is helping Salus automate critical security processes.

The AI race has to date been defined by scale – the larger the parameter-set the better – with Large language models (LLMs) dominating. However, as AI maturity has evolved, there is a growing ...

The diabetes market is booming, with continuous glucose monitoring (CGM) and GLP-1 drugs leading the charge in innovation and ...